Latest Breaking News On - Pharmaceutics ltd view - Page 1 : comparemela.com

NLS Pharmaceutics AG: NLS Pharmaceutics Announces Election of Additional Board Members

NLS Pharmaceutics AG: NLS Pharmaceutics Announces Election of Additional Board Members
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France generalFlorence allouche akninMarianne lambertsonClaudio basettiClaudio la bassettiAllouche akninStefan klotterAlex zwyerAllouch akninNeurology departmentPharmaceutics ltdBern university hospitalUniversity of zurichEuropean sleep research societyPharmaceutics ltd viewUniversity paris city

NLS Pharmaceutics AG: NLS Pharmaceutics to Participate in the Oppenheimer Sleep Disorders Summit: Deep Dive into Narcolepsy and Idiopathic Hypersomnia

NLS Pharmaceutics AG: NLS Pharmaceutics to Participate in the Oppenheimer Sleep Disorders Summit: Deep Dive into Narcolepsy and Idiopathic Hypersomnia
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Marianne lambertsonFrancois briseboisMichael thorpyStefan klotterAlex zwyerEdward mezerhaneSenior research biotechnology analystCentessa pharmaceuticalsPharmaceutics ltdAvadel pharmaceuticalsPharmaceutics ltd viewChief executive officerOppenheimer sleep disorders summitDeep diveIdiopathic hypersomniaManaging director

NLS Pharmaceutics AG: NLS Pharmaceutics Announces Receipt of Nasdaq Minimum Bid Price Notification

NLS Pharmaceutics AG: NLS Pharmaceutics Announces Receipt of Nasdaq Minimum Bid Price Notification
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Ihre chancenIndiens wirtschaftNasdaq stock marketPharmaceutics ltd viewCompany nasdaqPharmaceutics ltdExchange commissionListing ruleNasdaq listing ruleNasdaq capital marketLtd viewDer indienDie highlights

NLS Pharmaceutics AG: NLS Pharmaceutics to Present at the 35th Annual Roth Conference

ZURICH, SWITZERLAND / ACCESSWIRE / March 1, 2023 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development

United statesDana pointNewport beachDennis riedlAlex zwyerMarianne lambertsonBusiness servicesConsumer health wellnessPharmaceutics ltd viewOil gas metals miningPharmaceutics ltdAnnual rothLtd view

NLS Pharmaceutics AG: NLS Pharmaceutics Announces an R&D Update Webcast to Review the Company s Growing Portfolio of Pre-Clinical Compounds

Management to Discuss Pipeline Goals and Development Strategies across four Preclinical and 2 Clinical Programs across Multiple Central Nervous System (CNS) DisordersNLS to Webcast its R&D Day Event Tuesday

Marianne lambertsonEuropean patent officePharmaceutics ltd viewCompany rd dayInternational patent application noPharmaceutics ltdExchange commissionDevelopment strategiesDiscuss pipeline goalsMultiple central nervous systemDrug designationInternational patent applicationKleine levin syndromeLewy bodiesParkinson diseaseLewy body disease